4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000068
CHIEF OPERATING OFFICER sold 10,000 shares at an average $115.96 ($1,159,635)
- CHIEF OPERATING OFFICER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wassil Jim CHIEF OPERATING OFFICER | 2024-09-16 | Option exercise 10b5-1 | +10,000 | $2.42 | $24,200 | 211,958 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-09-16 | Sale 10b5-1 | −1,784 | $115.06 | $205,271 | 210,174 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-09-16 | Sale 10b5-1 | −7,994 | $116.14 | $928,399 | 202,180 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-09-16 | Sale 10b5-1 | −222 | $116.96 | $25,965 | 200,646 | D |
| Derivatives | |||||||
| Wassil Jim CHIEF OPERATING OFFICER | 2024-09-16 | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 42,638 | D | ||
| Open-market sales · 10,000 sh · avg $115.96 · $1,159,635 | |||||||
Loading xslF345X05/wk-form4_1726691002.xml…